There is a growing need for novel and effective therapeutics in the field of inflammatory
diseases, especially allergic asthma, chronic obstructive pulmonary diseases (COPD), fibrosis, acute respiratory distress
(ARDS) and viral infections such as influenza or COVID-19.
- Advice and technical support for a rapid and successful preclinical development for novel drug candidates to reach clinical phase studies.
- Innovative solutions to perform preclinical studies and in vitro and in vivo studies.
- Mechanistic studies in vitro and in vivo to identify mechanism of drug action.
- Networking with opinion leaders and scientists to ensure innovative new products and services.